{"entity":{"id":"nct04241315","kind":"trial","name":"ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting","aka":[],"tldr":"A phase 3 trial of Pafolacianine in Lung cancer, run by On Target Laboratories, LLC, completed.","summary":"ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting is a phase 3 interventional study registered as NCT04241315 by On Target Laboratories, LLC, with 112 participants recorded, started 2020-03-26 and reaching its primary completion in 2021-10-07. Interventions recorded: OTL38 for Injection, Near infrared camera imaging system. Conditions recorded: Lung Neoplasms, Lung Cancer.\n\nLinked to the drug Pafolacianine because the registry names it among its interventions and Lung cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT04241315","url":"https://clinicaltrials.gov/study/NCT04241315"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["pafolacianine"],"companies":["on-target-laboratories"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04241315","phase":"3","setting":"A Phase 3, Randomized,Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules","sponsor":"On Target Laboratories, LLC","enrolled":112,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04241315/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"drug":[{"id":"pafolacianine","kind":"drug","name":"Pafolacianine","route":"/drugs/pafolacianine/"}],"company":[{"id":"on-target-laboratories","kind":"company","name":"On Target Laboratories","route":"/companies/on-target-laboratories/"}]}}